|
시장보고서
상품코드
2126149
의료 시뮬레이션 시장(2026-2030년)Global Medical Simulation Market 2026-2030 |
||||||
세계의 의료 시뮬레이션 시장은 2025년부터 2030년까지 32억 5,420만 달러 증가하고, 예측 기간 동안 CAGR은 16.3%에 달할 것으로 예측됩니다.
세계 의료 시뮬레이션 시장에 관한 본 보고서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 벤더 분석을 제공합니다.
본 보고서는 현재 시장 상황, 최신 시장 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장은 환자 안전에 대한 관심 증가와 의료 과실 감소에 대한 요구, 가상현실(VR) 및 인공지능(AI) 분야의 기술 발전, 역량 기반 의학 교육 및 전문직 간 협력으로의 전환에 의해 주도되고 있습니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 및 2차 정보를 객관적으로 종합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석이 포함된 부문, 그리고 벤더 현황이 수록되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 대상 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 16% |
| CAGR | 16.3% |
| 증가액 | 32억 5,420만 달러 |
본 조사에서는 기기의 소형화 및 인시추(in situ) 시뮬레이션으로의 전환이 향후 수년간 세계 의료 시뮬레이션 시장의 성장을 견인할 주요 요인 중 하나라고 파악하고 있습니다. 또한, 환자 맞춤형 해부학적 모델 제작에 3D 프린팅의 도입이 확대되고, 기존의 임상 현장을 넘어선 시뮬레이션 용도가 확대됨에 따라 시장에서 상당한 수요가 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 최종사용자별
제9장 시장 세분화 : 솔루션별
제10장 시장 세분화 : 기술별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSM 26.09.08The global medical simulation market is forecasted to grow by USD 3254.2 mn during 2025-2030, accelerating at a CAGR of 16.3% during the forecast period. The report on the global medical simulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on patient safety and need to reduce medical errors, technological advancements in virtual reality and artificial intelligence, shift toward competency-based medical education and interprofessional collaboration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 16% |
| CAGR | 16.3% |
| Incremental Value | $3254.2 mn |
Technavio's global medical simulation market is segmented as below:
By End-User
- Academic institutes
- Military organizations
- Hospitals
- Others
By Solution
- Healthcare anatomical models
- Web-based simulators
- Simulation training services
- Healthcare simulation software
By Technology
- 3D printing
- Virtual patient simulation
- Procedural rehearsal technology
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the miniaturization of equipment and transition toward in-situ simulation as one of the prime reasons driving the global medical simulation market growth during the next few years. Also, increasing adoption of 3d printing for patient specific anatomical models and expansion of simulation applications beyond traditional clinical settings will lead to sizable demand in the market.
The report on the global medical simulation market covers the following areas:
- Global medical simulation market sizing
- Global medical simulation market forecast
- Global medical simulation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global medical simulation market vendors that include 3B Scientific GmbH, Anatomage Inc., Avkin Inc., Elevate Healthcare Inc., Gaumard Scientific Co. Inc., Kyoto Kagaku Co. Ltd., Laerdal Medical AS, Limbs and Things Ltd., Medical X, MedVision LLC, Mentice AB, Nasco Healthcare Inc., Operative Experience Inc., Oxford Medical Simulation Ltd., Simulab Corp., SimX Inc, Surgical Science Sweden AB, SynDaver Labs Inc., Trucorp Ltd., VirtaMed AG. Also, the global medical simulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Solution
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Medical Simulation Market 2020 - 2024
- Historic Market Size - Data Table on Global Medical Simulation Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Solution segment analysis 2020 - 2024
- Historic Market Size - Solution Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global medical simulation market
- 6.2 Impact of geopolitical conflicts on global medical simulation market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Academic institutes - Market size and forecast 2025-2030
- 8.4 Military organizations - Market size and forecast 2025-2030
- 8.5 Hospitals - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Solution
- 9.1 Market segments
- 9.2 Comparison by Solution
- 9.3 Healthcare anatomical models - Market size and forecast 2025-2030
- 9.4 Web-based simulators - Market size and forecast 2025-2030
- 9.5 Simulation training services - Market size and forecast 2025-2030
- 9.6 Healthcare simulation software - Market size and forecast 2025-2030
- 9.7 Market opportunity by Solution
- Market opportunity by Solution ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 3D printing - Market size and forecast 2025-2030
- 10.4 Virtual patient simulation - Market size and forecast 2025-2030
- 10.5 Procedural rehearsal technology - Market size and forecast 2025-2030
- 10.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing focus on patient safety and need to reduce medical errors
- Technological advancements in virtual reality and artificial intelligence
- Shift toward competency-based medical education and interprofessional collaboration
- 13.2 Market challenges
- High capital investment and ongoing operational costs
- Scarcity of qualified simulation instructors and specialized technicians
- Lack of standardization in simulation curricula and assessment metrics
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Miniaturization of equipment and transition toward In-Situ simulation
- Increasing adoption of 3D printing for patient specific anatomical models
- Expansion of simulation applications beyond traditional clinical settings
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 3B Scientific GmbH
- 3B Scientific GmbH - Overview
- 3B Scientific GmbH - Product / Service
- 3B Scientific GmbH - Key offerings
- SWOT
- 15.5 Anatomage Inc.
- Anatomage Inc. - Overview
- Anatomage Inc. - Product / Service
- Anatomage Inc. - Key offerings
- SWOT
- 15.6 Elevate Healthcare Inc.
- Elevate Healthcare Inc. - Overview
- Elevate Healthcare Inc. - Product / Service
- Elevate Healthcare Inc. - Key offerings
- SWOT
- 15.7 Gaumard Scientific Co. Inc.
- Gaumard Scientific Co. Inc. - Overview
- Gaumard Scientific Co. Inc. - Product / Service
- Gaumard Scientific Co. Inc. - Key offerings
- SWOT
- 15.8 Kyoto Kagaku Co. Ltd.
- Kyoto Kagaku Co. Ltd. - Overview
- Kyoto Kagaku Co. Ltd. - Product / Service
- Kyoto Kagaku Co. Ltd. - Key offerings
- SWOT
- 15.9 Laerdal Medical AS
- Laerdal Medical AS - Overview
- Laerdal Medical AS - Product / Service
- Laerdal Medical AS - Key offerings
- SWOT
- 15.10 Limbs and Things Ltd.
- Limbs and Things Ltd. - Overview
- Limbs and Things Ltd. - Product / Service
- Limbs and Things Ltd. - Key offerings
- SWOT
- 15.11 MedVision LLC
- MedVision LLC - Overview
- MedVision LLC - Product / Service
- MedVision LLC - Key offerings
- SWOT
- 15.12 Mentice AB
- Mentice AB - Overview
- Mentice AB - Business segments
- Mentice AB - Key offerings
- Mentice AB - Segment focus
- SWOT
- 15.13 Nasco Healthcare Inc.
- Nasco Healthcare Inc. - Overview
- Nasco Healthcare Inc. - Product / Service
- Nasco Healthcare Inc. - Key offerings
- SWOT
- 15.14 Oxford Medical Simulation Ltd.
- Oxford Medical Simulation Ltd. - Overview
- Oxford Medical Simulation Ltd. - Product / Service
- Oxford Medical Simulation Ltd. - Key offerings
- SWOT
- 15.15 Surgical Science Sweden AB
- Surgical Science Sweden AB - Overview
- Surgical Science Sweden AB - Business segments
- Surgical Science Sweden AB - Key offerings
- Surgical Science Sweden AB - Segment focus
- SWOT
- 15.16 SynDaver Labs Inc.
- SynDaver Labs Inc. - Overview
- SynDaver Labs Inc. - Product / Service
- SynDaver Labs Inc. - Key offerings
- SWOT
- 15.17 Trucorp Ltd.
- Trucorp Ltd. - Overview
- Trucorp Ltd. - Product / Service
- Trucorp Ltd. - Key offerings
- SWOT
- 15.18 VirtaMed AG
- VirtaMed AG - Overview
- VirtaMed AG - Product / Service
- VirtaMed AG - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
